FDA Clearance Tracker · P150031-S076
Vercise DBS Controller
Last checked: Nov 20, 2026Latest source record: Feb 5, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Feb 5, 2025
Approved
Time to decision
215 days
Received Jul 5, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150031-S076
- Device name
- Vercise DBS Controller
- Applicant
- Boston Scientific Corp
- Applicant location
- Valencia, CA
- Received
- Jul 5, 2024
- Decided
- Feb 5, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150031
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for the Vercise DBS Controller, a mobile application intended to function as an alternate to the current Vercise Remote Control (RC) 4 (approved in P150031/S034) to control the Vercise Genus DBS Implantable Pulse Generator (IPG) and External Trial Stimulator (ETS)
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.